The Lung Cancer Policy Network has published our 2023 in review: building the evidence base report, detailing what the Network and its members have achieved over the past year. Throughout our outputs and activities in 2023, we sought to demonstrate the breadth of evidence there is to support reducing lung cancer mortality rates.
Over the past year, our global Network membership has grown in number, with the Network now representing 24 countries across 6 continents. The scope of Network member knowledge has been key in developing impactful and practical outputs for policy engagement, and collaboration between the Network and its members facilitates for the delivery of resources that evidence-based and consensus-driven.
We hope that this report will be useful for Network funders, members and the general public in understanding the impact of Network activities.
As we look ahead to 2024, we will still be seeking to grow the Network membership and collaborate with organisations that share our vision of making lung cancer a policy priority. In particular, we will be focusing on driving policy action this year.
Recent news
Blog
Lung cancer: the looming economic crisis governments can’t ignore
Lung cancer carries a heavy cost – not only for the people diagnosed, but for health systems and economies alike.
Blog
Beyond lung cancer: how LDCT screening could reshape early detection
Health systems are under growing strain. The challenge is no longer simply how to treat illness, but how to detect it earlier and manage it more efficiently.
News
Insights from the I-ELCAP 3rd Annual AGILEᴰˣᴿˣ meeting
In March, the Network attended the International Early Lung Cancer Action Program 3rd Annual AGILEᴰˣᴿˣ meeting in Gdańsk, Poland.